Clinical Trial
doi: 10.1016/j.vaccine.2003.11.044.
Safety, reactogenicity and immunogenicity of a combined hexavalent tetanus, diphtheria, acellular pertussis, hepatitis B, inactivated poliovirus vaccine and Haemophilus influenzae type b conjugate vaccine, for primary immunization of infants
Affiliations
- PMID: 15149781
- DOI: 10.1016/j.vaccine.2003.11.044
Item in Clipboard
Clinical Trial
Safety, reactogenicity and immunogenicity of a combined hexavalent tetanus, diphtheria, acellular pertussis, hepatitis B, inactivated poliovirus vaccine and Haemophilus influenzae type b conjugate vaccine, for primary immunization of infants
Vaccine.
.
Abstract
Safety, reactogenicity and immunogenicity of GSK Biologicals' hexavalent DTPa-HBV-IPV/Hib vaccine (Infanrix)hexa) was assessed when used for primary vaccination at 3, 4 and 5 months of age (N = 2163), compared to the separate administration of DTPa-IPV/Hib and HBV vaccines (N = 720). A similar safety and reactogenicity profile was demonstrated for both vaccine regimens, as well as a good immune response for all antigen components. By offering protection against six diseases in a series of single injections, the hexavalent DTPa-HBV-IPV/Hib vaccine was shown to be a safe, well tolerated and immunogenic alternative to primary immunization with licensed separately administered vaccines.
Similar articles
-
Immunogenicity and reactogenicity of two regimens of diphtheria-tetanus-acellular pertussis-hepatitis B-inactivated polio and Haemophilus influenzae type b vaccines administered to infants primed at birth with hepatitis B vaccine.Southeast Asian J Trop Med Public Health. 2004 Sep;35(3):685-92. Southeast Asian J Trop Med Public Health. 2004. PMID: 15689088 Clinical Trial.
-
Immunogenicity, reactogenicity and safety of a 7-valent pneumococcal conjugate vaccine (PCV7) concurrently administered with a DTPa-HBV-IPV/Hib combination vaccine in healthy infants.Vaccine. 2006 May 29;24(22):4727-36. doi: 10.1016/j.vaccine.2006.03.032. Epub 2006 Mar 24. Vaccine. 2006. PMID: 16616973 Clinical Trial.
-
Booster immunization with a hexavalent diphtheria, tetanus, acellular pertussis, hepatitis B, inactivated poliovirus vaccine and Haemophilus influenzae type b conjugate combination vaccine in the second year of life: safety, immunogenicity and persistence of antibody responses.Vaccine. 2007 Jan 22;25(6):1055-63. doi: 10.1016/j.vaccine.2006.09.060. Epub 2006 Oct 2. Vaccine. 2007. PMID: 17049692 Clinical Trial.
-
Immunization of preterm infants with GSK's hexavalent combined diphtheria-tetanus-acellular pertussis-hepatitis B-inactivated poliovirus-Haemophilus influenzae type b conjugate vaccine: A review of safety and immunogenicity.Vaccine. 2018 Feb 8;36(7):986-996. doi: 10.1016/j.vaccine.2018.01.005. Epub 2018 Jan 12. Vaccine. 2018. PMID: 29336924 Review.
-
Spotlight on DTPa-HBV-IPV/Hib Vaccine (Infanrix hexa).BioDrugs. 2010 Oct 1;24(5):299-302. doi: 10.2165/11206690-000000000-00000. BioDrugs. 2010. PMID: 20795752 Review.
Cited by
-
Immunogenicity and safety of a combined DTPa-IPV/Hib vaccine administered as a three-dose primary vaccination course in healthy Korean infants: phase III, randomized study.Hum Vaccin Immunother. 2019;15(2):317-326. doi: 10.1080/21645515.2018.1536588. Epub 2018 Nov 15. Hum Vaccin Immunother. 2019. PMID: 30431387 Free PMC article. Clinical Trial.
-
Immunogenicity and safety following primary and booster vaccination with a hexavalent diphtheria, tetanus, acellular pertussis, hepatitis B, inactivated poliovirus and Haemophilus influenzae type b vaccine: a randomized trial in the United States.Hum Vaccin Immunother. 2019;15(4):809-821. doi: 10.1080/21645515.2018.1549449. Epub 2019 Jan 4. Hum Vaccin Immunother. 2019. PMID: 30444673 Free PMC article. Clinical Trial.
-
DTPa-HBV-IPV/Hib Vaccine (Infanrix hexa): A Review of its Use as Primary and Booster Vaccination.Drugs. 2010 May 28;70(8):1021-58. doi: 10.2165/11204830-000000000-00000. Drugs. 2010. PMID: 20481658 Review.
-
Comparison of the tolerability of newly introduced childhood vaccines in the Netherlands.Eur J Pediatr. 2017 Jun;176(6):757-768. doi: 10.1007/s00431-017-2901-4. Epub 2017 Apr 20. Eur J Pediatr. 2017. PMID: 28429115
-
Combined DTP-HBV-HIB vaccine versus separately administered DTP-HBV and HIB vaccines for primary prevention of diphtheria, tetanus, pertussis, hepatitis B and Haemophilus influenzae B (HIB).Cochrane Database Syst Rev. 2012 Apr 18;2012(4):CD005530. doi: 10.1002/14651858.CD005530.pub3. Cochrane Database Syst Rev. 2012. PMID: 22513932 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
